New York authorities will vaccinate citizens at home
'23.02.2021'
Olga Derkach
Johnson & Johnson said Tuesday, February 23, that it will provide 20 million of the country's first single-dose COVID-19 vaccines by the end of March. Thanks to this, New York promises to provide vaccinations at home in the near future. Writes about it New York Post.
“The main thing we want to achieve is vaccination at home of people who cannot arrive at vaccination points. It really does require the Johnson & Johnson vaccine, ”said New York Mayor Bill de Blasio.
City Health Commissioner Dave Chokshi said J&J testimony to the US House of Representatives Vaccine Development Subcommittee suggests the city could begin home vaccinations as early as next month.
“We will be ready to get our seniors home immunized very quickly within a month,” he said.
“We hope everything goes according to plan in March and we will be vaccinating on the basis of supplies allocated by the federal government,” Chokshi said, referring to federal approval, which the J&J vaccine still needs.
On the subject: Getting COVID-19 vaccine out of turn will be a felony in New York
On February 4, the company filed for approval from the Food and Drug Administration (FDA). The city called the vaccine a game-changer because it only takes one dose and is much easier to store than competing vaccines.
Johnson & Johnson vice president Dr. Richard Nettles told members of the House Energy and Commerce Oversight and Investigation Subcommittee that he now has 4 million doses of vaccine ready to ship.
“By the end of March, we will have 20 million doses of vaccine, and we are ready to ship them as soon as we get approval,” Nettles said.
The company expects to have delivered 100 million doses by the end of June.
On the subject: Scammers use COVID-19 vaccination to steal data and money from New Yorkers: how to protect yourself
Other manufacturers have also provided a summary of the total doses they expect to ship to the US.
By the end of March, Pfizer expects to ship 120 million and Moderna 100 million. Both companies expect to have 200 million doses by the end of May, and Moderna 300 million by the end of July.
Novavax, which has yet to validate its vaccine, said it would have 110 million doses for the US by the third quarter of the year. Oxford-AstraZeneca will provide a total of 300 million doses.
